Segment Reporting (Tables)

6 Months Ended

Jun. 30, 2016

Segment Reporting [Abstract]

Summary Of Segment Performance

	For the Three Months Ended June 30,
		CAG	Water		LPD		Other		Unallocated Amounts		Consolidated Total
2016
Revenue	$	400,223	$	27,829	$	32,856	$	5,661	$	-	$	466,569
Income (loss) from operations	$	91,019	$	12,743	$	5,069	$	(920)	$	(3,749)	$	104,162
Interest expense, net												(7,276)
Income before provision for income taxes												96,886
Provision for income taxes												29,680
Net income												67,206
Less: Net income attributable to noncontrolling interest												4
Net income attributable to IDEXX  Laboratories, Inc. stockholders											$	67,202
2015
Revenue	$	351,620	$	25,051	$	32,059	$	4,613	$	-	$	413,343
Income (loss) from operations	$	68,085	$	11,951	$	6,579	$	(933)	$	2,621	$	88,303
Interest expense, net												(6,700)
Income before provision for income taxes												81,603
Provision for income taxes												24,665
Net income												56,938
Less: Net income attributable to noncontrolling interest												26
Net income attributable to IDEXX  Laboratories, Inc. stockholders											$	56,912

	For the Six Months Ended June 30,
		CAG	Water		LPD		Other		Unallocated Amounts		Consolidated Total
2016
Revenue	$	757,862	$	51,381	$	63,712	$	11,164	$	-	$	884,119
Income (loss) from operations	$	152,397	$	22,422	$	9,639	$	(1,757)	$	(4,746)	$	177,955
Interest expense, net												(14,760)
Income before provision for income taxes												163,195
Provision for income taxes												49,964
Net income												113,231
Less: Net income attributable to noncontrolling interest												10
Net income attributable to IDEXX  Laboratories, Inc. stockholders											$	113,221
2015
Revenue	$	676,151	$	46,749	$	63,329	$	9,591	$	-	$	795,820
Income (loss) from operations	$	121,603	$	21,312	$	13,535	$	(1,255)	$	5,911	$	161,106
Interest expense, net												(12,579)
Income before provision for income taxes												148,527
Provision for income taxes												45,011
Net income												103,516
Less: Net income attributable to noncontrolling interest												10
Net income attributable to IDEXX  Laboratories, Inc. stockholders											$	103,506

Summary Of Revenue By Product And Service Category

	For the Three Months Ended				For the Six Months Ended
	June 30,				June 30,
		2016		2015		2016		2015
CAG segment revenue:
CAG Diagnostics recurring revenue:	$	338,298	$	300,146	$	643,808	$	578,911
IDEXX VetLab® consumables		114,561		100,743		222,520		199,135
IDEXX VetLab service and accessories		14,826		14,018		28,583		27,548
Rapid assay products		55,777		52,182		98,863		95,819
Reference laboratory diagnostic and consulting services		153,134		133,203		293,842		256,409
CAG Diagnostics capital - instruments		32,520		24,064		55,494		44,178
Veterinary software, services and diagnostic imaging systems (1)		29,405		27,410		58,560		53,062
CAG segment revenue		400,223		351,620		757,862		676,151
Water segment revenue		27,829		25,051		51,381		46,749
LPD segment revenue		32,856		32,059		63,712		63,329
Other segment revenue		5,661		4,613		11,164		9,591
Total revenue	$	466,569	$	413,343	$	884,119	$	795,820
(1) During the second quarter of 2016, we renamed our customer information management and diagnostic imaging systems line of business in the CAG segment to veterinary software, services and diagnostic imaging systems. Financial results were not adjusted as a result of this name change.